AIM WINNERS & LOSERS: Deltex plummets on return to AIM; Blancco rises
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read moreWed, 17th Jun 2020 12:01
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read moreFriday 14 July | |
Templeton Emerging Markets Investment Trust PLC | AGM |
Monday 17 July | |
All ThingsConsidered Group PLC | AGM |
Tower Resources PLC | AGM |
Tuesday 18 July | |
Alkemy Capital Investments PLC | AGM |
Bloomsbury Publishing PLC | AGM |
CT Property Trust Ltd | GM re takeover by LondonMetric Property |
e-Therapeutics PLC | AGM |
MobilityOne Ltd | EGM re Tete planned JV deadline extension |
SmartSpace Software PLC | AGM |
Strategic Minerals PLC | AGM |
Wynnstay Properties PLC | AGM |
Wednesday 19 July | |
Berkeley Energia Ltd | AGM |
Caledonian Trust PLC | AGM |
DG Innovate PLC | AGM |
Experian PLC | AGM |
HICL Infrastructure PLC | AGM |
Mind Gym PLC | AGM |
Sportech PLC | GM re share capital restructure |
Triple Point Income VCT PLC | AGM |
Thursday 20 July | |
ACG Acquisition Co Ltd | EGM re acquisition of the Atlantic Nickel |
Big Yellow Group PLC | AGM |
CT UK High Income Trust PLC | AGM |
Evgen Pharma PLC | AGM |
FD Technologies PLC | AGM |
Fuller, Smith & Turner PLC | AGM |
GB Group PLC | AGM |
Halma PLC | AGM |
Intermediate Capital Group PLC | AGM |
International Distributions Services PLC | AGM |
Fidelity China Special Situations PLC | AGM |
Johnson Matthey PLC | AGM |
Kingspan Group PLC | EGM re delisting |
Pennon Group PLC | AGM |
Premier Foods PLC | AGM |
Premier Miton Group PLC | AGM |
Qinetiq Group PLC | AGM |
SSE PLC | AGM |
TR Property Investment Trust PLC | AGM |
VP PLC | AGM |
Weiss Korea Opportunity Fund Ltd | AGM |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - Evgen Pharma PLC on Tuesday said its lead asset SFX-01 has radio-sensitising effects in vivo in a form of soft tissue sarcoma, as part of its research partnership with Sapienza University of Rome.
Read more(Alliance News) - Evgen Pharma PLC on Monday said its collaborator at the Erasmus University Medical Center in Rotterdam has received notice of a grant from KWF Dutch Cancer Society.
Read more(Alliance News) - Evgen Pharma PLC on Wednesday reported a widened annual loss and said its Chief Financial Officer Richard Moulson will retire in late July.
Read moreThursday 1 June | |
Auto Trader Group PLC | Full Year Results |
Dr Martens PLC | Full Year Results |
Pennon Group PLC | Full Year Results |
Trinity Exploration & Production PLC | Full Year Results |
Friday 2 June | |
TR Property Investment Trust PLC | Full Year Results |
Nostrum Oil & Gas PLC | Full Year Results |
Monday 5 June | |
Celadon Pharmaceuticals PLC | Full Year Results |
Hercules Site Services PLC | Half Year Results |
Itaconix PLC | Full Year Results |
Sirius Real Estate Ltd | Full Year Results |
ValiRx PLC | Full Year Results |
Verici Dx PLC | Full Year Results |
Tuesday 6 June | |
British American Tobacco PLC | Trading Statement |
Chemring Group PLC | Half Year Results |
Ferguson PLC | Q3 Results |
Gooch & Housego PLC | Half Year Results |
Jadestone Energy PLC | Full Year Results |
N Brown Group PLC | Full Year Results |
NewRiver REIT PLC | Full Year Results |
Oxford Metrics PLC | Half Year Results |
Paragon Banking Group PLC | Half Year Results |
Speedy Hire PLC | Full Year Results |
Warehouse REIT PLC | Full Year Results |
Wednesday 7 June | |
discoverIE Group PLC | Full Year Results |
Evgen Pharma PLC | Full Year Results |
LXi REIT PLC | Full Year Results |
Ramsdens Holdings PLC | Half Year Results |
Residential Secure Income PLC | Half Year Results |
Vp PLC | Full Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
Evgen Pharma PLC - Cheshire, England-based clinical stage drug development company focusing on sulforaphane-based medicines - Presents top line pharmacokinetic data for its placebo-controlled, dose-escalating, randomised Phase I/Ib clinical trial. Says the study is aimed to provide further insight into the pharmacokinetic and pharmacodynamic characteristics of the new enteric coated tablet formulation of the company's lead asset SFX-01, as well as investigating how sulforaphane released from the tablet engages with targets of interest. Says SFX-01 shows no serious adverse effects and the study is on schedule for full reporting in the second quarter.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read more(Alliance News) - Evgen Pharma PLC said on Thursday it had found further evidence of radiosensitisation by SFX-01 in sarcoma cells.
Read more(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read more(Alliance News) - Evgen Pharma PLC on Wednesday said it completed the dosing of all three cohorts of the phase 1/1b clinical trial of its SFX-01 tablet formulation.
Read more(Alliance News) - Evgen Pharma PLC on Thursday said interim loss widened, but noted the healthy volunteer study of its SFX-01 formulation remains on schedule.
Read more(Alliance News) - Evgen Pharma PLC said on Wednesday it had started a randomised, placebo-controlled clinical trial of its new SFX-01 tablet.
Read more(Sharecast News) - Clinical-stage drug developer Evgen Pharma has dosed the first group of healthy volunteers in its placebo-controlled, dose-escalating, randomised phase 1 and 1b clinical trial, it announced on Wednesday.
Read more